Compare Research Peptides

Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.

Peptide 1

Peptide 2

	CJC-1295 CJC-1295 with DAC Sign up to track	Ipamorelin IPA Sign up to track
Category	Growth Hormone Secretagogues	Growth Hormone Secretagogues
Key Benefits	•Increases growth hormone and IGF-1 levels •Promotes muscle growth and fat loss •Improves recovery and sleep quality •Enhances bone density +1 more	•Stimulates growth hormone release •Minimal effect on cortisol and prolactin •Supports lean muscle mass development •Aids in fat metabolism and anti-aging +2 more
Dosage	100-200 mcg (no DAC) or 2 mg (with DAC) mcg	200-300 mcg mcg
Frequency	Daily before bed (no DAC) or Once weekly (with DAC)	1-3x daily
Administration	Subcutaneous	Subcutaneous
Mechanism	CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the release of growth hormone from the pituitary gland. It comes in two forms: with DAC (Drug Affinity Complex) for longer action, and without DAC for shorter, more frequent dosing.	Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin and stimulates the release of growth hormone from the pituitary gland. It is one of the cleanest GH-releasing peptides with minimal effect on cortisol and prolactin levels.
Side Effects / Risks	Not specified	Not specified
Research Status	Research compound - not FDA approved for these uses	Research compound - not FDA approved